The final section pounding the desk about how terrible ending the program was seems like it is oddly at variance with all the evidence OP had just laid out about how the program wasn't working well anymore and so wasn't actually financially a good idea. It's weird to quote a bunch of things like studies showing that 'internal R&D spending works worse than external for ROI' and then write a big moralizing sermonizing conclusion about how ending internal R&D is bad for profits and how terrible it is there's no 'patient capital' (capital which was plenty available before - what's the theory, investors stopped liking making money? insurance companies with century-long investment horizons ceased to exist? etc).